Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor
US8846695B2 · kind B2 · utility
45Cited by
107References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 7, 2010 |
| Grant date | Sep 30, 2014 |
| Priority date | — |
| Expiry date | Jun 4, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for improving glycemic control in type 2 diabetes patients with inadequate glycemic control despite metformin therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.